Published
Docking of Hematoporphyrin on various Anticancer Drugs targeting enzymes
Published in June 2016 Issue 3 (Vol. 6, Issue 3, 2016)

Abstract
The present study deals with docking of Hematoporphrin with various anticancer drugs targeting enzymes. The targets used were PDB-ID 2Y3I, PDB-ID 3OZZ, PDB-ID 3UEN and PDB-ID 4O33. Hematoporphyrin docked with these enzymes and interactions between the enzyme and compound were measured and compared with standard Paclitaxel. The study concluded that, the compound (Hematoporphyrin) isolated from plant were high interactions with PDB-ID 4O33 when compared to standard.
Authors (3)
Nandhini Sundaresan
View all publications →Radha Ramalingam
View all publications →Vadivu Rajendren
View all publications →Download Article
Best for printing and citation
File size: 0.0 MB
Format: PDF
Download Article
Best for printing and citation
File size: 0.0 MB
Format: PDF
Article Information
Published in:
June 2016 Issue 3 (Vol. 6, Issue 3, 2016)AJPTR63013
AJPTR-01-001019
2016-06-01
Article Impact
Views:2,675
Downloads:754
How to Cite
Sundaresan & Ramalingam & Rajendren (2016). Docking of Hematoporphyrin on various Anticancer Drugs targeting enzymes. American Journal of PharmTech Research, 6(3), xx-xx. https://ajptr.com/articles/AJPTR63013
Article Actions
More from this Issue
Management of co- morbid depression in Diabetic patients : A Review
Aswathy Vijayan, Roshin E...Read more →
Approaches and advances in transdermal delivery of insulin -A Review
Jigyasa vindru, Aravind R...Read more →
Type 2 Diabetes Mellitus and Metabolic Syndrome
Dhanya Hariharan, Shibina...Read more →
More by These Authors
Formulation and Process Optimization of Quetiapine Fumarate Nanosuspension using Factorial Design
2015 • Vol. 5, Issue 5
Read more →A Pharmacognostic and Phytopharmacological Overview on Bombax Ceiba.
2018 • Vol. 8, Issue 6
Read more →